tremity, pitting edema extending to the mid-thigh. No other abnormalities were found. Urinalysis revealed 4ϩ proteinuria, numerous hyaline casts, and no hematuria or leukocyturia. A 24-hour urine collection contained 10 g of protein.
tions of NS. Nephrotic hyperlipidemia is marked by appendectomy 17 years ago. Because the patient was adopted elevations of plasma low-density lipoprotein (LDL), very when she was 2 years old, her family history was unknown. ratios of cholesterol to triglycerides, free cholesterol to
low-density lipoprotein (VLDL), intermediate-density
The current physical examination was notable for mild hypertension (140/90 mm Hg) and marked bilateral, lower excholesterol esters, and phospholipids to proteins are significantly increased in all lipoprotein fractions in NS [6] . These alterations are accompanied by impaired clear-
LDL and cholesterol metabolism
regulate, HMG-CoA reductase, and glucagon counteracts insulin's action [14] . Plasma LDL and total cholesterol are markedly eleIn our initial study of rats with puromycin-induced NS vated in NS. Elevation of plasma LDL in NS is thought (a popular model of minimal-change disease), we found to be due to increased LDL synthesis [7] and depressed a marked up-regulation of HMG-CoA reductase mRNA LDL catabolism [1] . In fact, Warwick et al [10, 12] have and enzymatic activity during the induction phase of prodemonstrated a significant reduction in the rate of catabteinuria and hypercholesterolemia [15] . These changes olism of apolipoprotein B (Apo B), the principal apowere followed by a gradual decline in HMG-CoA reductase protein constituent of LDL. Most of the earlier studies mRNA and activity toward baseline values despite persisof lipid metabolism in NS had focused on characterizatent hypercholesterolemia during the chronic phase of NS. tion of the plasma lipid profile, determination of the Interestingly, withdrawal of food for 20 hours resulted in rate of clearance of labeled lipoprotein fractions, indirect a pronounced but transient up-regulation of HMG-CoA measurements of lipid biosynthesis, and apoprotein exNS, rats with diet-induced hyperlipidemia, and normal Ch 7␣-hydroxylase expressions in nephrotic animals [15, 18] . control rats. The study revealed a marked up-regulation Regulation of HMG-CoA reductase, Ch 7␣-hydroxyof Ch 7␣-hydroxylase mRNA and immunodetectable prolase, and other cholesterol-responsive factors by cholestein in rats with diet-induced hypercholesterolemia. Howterol depends on intracellular free cholesterol as opposed ever, despite equally severe hypercholesterolemia, nephto cholesterol esters, which constitute the bulk of the rotic rats showed no rise in either Ch 7␣-hydroxylase cellular cholesterol pool. Given the importance of cellumRNA or protein abundance [16, 18] . In a subsequent lar free-cholesterol concentration and the cholesterol esstudy, we found that bile secretion rate was markedly terification system in cholesterol metabolism, we examelevated in rats with diet-induced hypercholesterolemia ined gene expression, protein abundance, and enzymatic but was virtually unchanged in the nephrotic rats, thus activity of the liver-specific enzyme ACAT-2, which is demonstrating the inability of nephrotic animals to inresponsible for esterification of cholesterol in the liver crease bile secretion rate in response to severe hypercho- [16, 21] . lesterolemia [19] .
Primarily localized in the endoplasmic reticulum, ACAT To discern the reason for the disparity in hepatic catalyzes intracellular esterification of cholesterol and HMG-CoA reductase and Ch 7␣-hydroxylase expression formation of cholesterol esters in nearly all mammalian between the nephrotic and diet-induced hypercholestercells. Recently, two distinct isoforms of ACAT, ACAT-1 olemias, we measured intracellular cholesterol concenand ACAT-2, have been identified in the hepatocytes tration, which plays a major role in the regulation of these of humans and animals [22] [23] [24] . ACAT-1 is ubiquitously enzymes. The study showed a 16-fold increase in hepatic expressed in all tissues, whereas ACAT-2 is primarily tissue cholesterol content in rats with diet-induced hyexpressed in the liver and intestine. Esterification of chopercholesterolemia, but no increase in the nephrotic anilesterol by ACAT limits its solubility in the cell memmals despite equally severe hypercholesterolemia [15, 18] .
brane lipids and promotes accumulation of cholesterol These observations point to the lack of rise in hepatocelesters in the fat droplets. By modulating intracellular free lular cholesterol content as an underlying mechanism cholesterol concentration, ACAT regulates cholesterol for the observed dysregulation of HMG-CoA reductase signaling pathways [25] . In addition, ACAT-mediated and Ch 7␣-hydroxylase in NS. To elucidate the mechaesterification of cholesterol contributes to production, nism of the observed discordance in plasma and hepatopackaging, and release of VLDL by the liver [26] . Finally, cyte cholesterol levels, we next explored the effect of ACAT contributes to cholesterol ester accumulation in NS on LDL receptor expression.
macrophages and vascular tissue, hence, foam cell formaHepatic cholesterol uptake represents the primary pathtion and atherosclerosis [27] . way of cholesterol clearance from the circulation. We
Free cholesterol regulates HMG-CoA reductase and therefore considered that discordance between plasma Ch 7␣-hydroxylase, and ACAT modulates cellular free and hepatocyte cholesterol concentrations and the resulcholesterol level, so we hypothesized that dysregulation tant dysregulations of HMG-CoA reductase [15, 16] and of lipid metabolism in NS in part reflects a possible upCh 7␣-hydroxylase [16, 18] in NS might be partly due regulation of hepatic ACAT activity. Therefore we deterto impaired hepatic cholesterol uptake. As the LDL remined the mRNA abundance, immunodetectable protein, ceptor provides the predominant pathway for plasma and enzymatic activity of the liver-specific ACAT-2 in rats cholesterol clearance, we hypothesized that NS results with chronic NS caused by either puromycin or spontanein acquired LDL receptor deficiency. To test this hypothous focal glomerulosclerosis and compared the results esis, we determined LDL receptor mRNA and protein with those obtained in normal control rats [16, 21] . To abundance and gene transcription rate in the livers of dissect the effect of proteinuria from that of hypoalbuminephrotic and control rats [16, 20] . The results showed nemia, we included a group of Nagase rats with heredisevere reduction of hepatic LDL receptor protein abuntary analbuminemia in the study. The nephrotic animals dance in the nephrotic animals despite normal LDL reexhibited a 3-to 4-fold increase in liver tissue ACAT-2 ceptor mRNA abundance and gene transcription rate.
mRNA and protein abundance as well as enzymatic acThe latter findings point to inefficient translation and/or tivity. The increase was accompanied by a significant increased LDL receptor protein turnover as a cause of reduction of hepatic tissue free-cholesterol concentra-LDL receptor deficiency in NS. Given the critical role tion, which provided functional evidence for excess of LDL receptor, acquired LDL receptor deficiency must ACAT-2 activity in the nephrotic liver. In contrast, decontribute to hypercholesterolemia, elevation of plasma spite extreme hypoalbuminemia, rats with hereditary an-LDL, impaired LDL clearance [10] , and inappropriately albuminemia showed only a mild elevation of hepatic low hepatocellular cholesterol in NS. The reduction in ACAT-2 mRNA, protein, and enzymatic activity. Hehepatocellular cholesterol concentration can, in part, acpatic ACAT-2 protein and activity strongly correlated with plasma lipid concentrations and urinary protein count for dysregulation of HMG-CoA reductase and excretion. The study therefore demonstrated a marked Apo A-II (20% of HDL protein), which are produced by the liver and intestine. (The remaining 10% consist up-regulation of hepatic ACAT-2 and its possible contribution to the associated dyslipidemia in NS. The study of Apo A-IV, Apo C, and Apo E.) These apoproteins are secreted with VLDL and chylomicrons. After reaching further showed that elevation of hepatic ACAT-2 in NS is primarily due to proteinuria as opposed to hypoalbuthe extracellular space, Apo A-I and Apo A-II disassociate from the original particles as phospholipid complexes minemia [21] . The observed overexpression of hepatic ACAT-2 can, in part, contribute to dysregulation of and coalesce to form the nascent HDL. Subsequently, nascent HDL particles incorporate Apo C-phospholipid HMG-CoA reductase and Ch 7␣-hydroxylase [28] by lowering intracellular free-cholesterol concentration while
and Apo E-phospholipid complexes, which are either derived from lipolysis of VLDL and chylomicrons by simultaneously generating abundant supplies of cholesterol esters for incorporation into Apo B-containing lipolipoprotein lipase or are directly secreted by the liver. These events lead to formation of small cholesterol-poor proteins.
To determine the effect of NS on the intestinal trans-HDL-3 particles. As reviewed by Genest et al [29] , retrieval of surplus cholesterol by the small cholesterolport of cholesterol, we measured the rate of absorption of micellar preparations of cholesterol in nephrotic, dietpoor discoid HDL particle begins with its attachment to the cell surface via HDL-binding protein, which has been induced hypercholesterolemic, and in control rats. The results showed no significant difference in the rates of shown to be identical to vigilin. The binding of HDL to its binding protein leads to mobilization of intracellular cholesterol absorption among the study groups. Thus, neither nephrotic hyperlipidemia nor diet-induced hypercholesterol pools and translocation of free cholesterol via the Golgi apparatus to the caveolae and ultimately lipidemia affects intestinal absorption of cholesterol [19] .
In sum, NS is associated with a relative elevation of to the plasma membrane. Accumulation of free cholesterol in the plasma membrane generates a concentration hepatic HMG-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis, and with a relative reduction gradient favoring its diffusion to the surface of the HDL particle. Free cholesterol reaching the surface of HDL is of Ch 7␣-hydroxylase, the rate-limiting enzyme in cholesterol catabolism. These alterations are accompanied by, immediately esterified by the enzyme lecithin:cholesterol acyltransferase (LCAT) in the presence of its cofactor and are at least in part due to, LDL receptor deficiency, which limits hepatic cholesterol uptake, and up-regulation Apo A-I to form cholesterol ester. Because of its intense hydrophobicity, cholesterol ester formed on the surface of hepatic ACAT-2, which lowers hepatocyte free-cholesterol concentration. These molecular events can account sinks into the core of the HDL particle, thus sustaining the favorable gradient for maximal cholesterol uptake for the induction and maintenance of nephrotic hypercholesterolemia, impaired LDL clearance, and cholesby the maturing HDL. Once fully loaded, the cholesterol ester-rich HDL particle dissociates from the HDL bindterol enrichment of VLDL and newly synthesized LDL particles.
ing protein and returns to the circulation for transport to the liver. In the circulation, the cholesterol ester-rich HDL metabolism HDL-2 particle donates part of its cholesterol ester cargo to VLDL remnants (IDL) in exchange for triglycerides. The primary function of HDL is retrieval of surplus cholesterol from extrahepatic tissues for disposal in the This process is facilitated by plasma cholesterol ester transfer protein (CETP), which is present in humans but liver. Cholesterol ester delivery by HDL to the liver can occur either directly via receptor-mediated processes or absent in rats. In addition, HDL acquires Apo C and Apo E from VLDL and chylomicron remnants for subseindirectly via transfer of cholesterol esters to Apo B 100 -containing particles and their uptake by LDL receptor or quent donation to the nascent VLDL and chylomicrons. These events lead to further reduction of triglyceride by LDL-receptor-related protein (LRP). HDL-mediated cholesterol retrieval, commonly known as reverse cholescontent of the VLDL remnants, thus contributing to their eventual conversion to LDL or hepatic removal by either terol transport, is essential for cellular cholesterol homeostasis and protection against atherosclerotic cardiovascu-LDL receptors or LRP-mediated endocytosis. Extraction of Apo C proteins from the remnant particles by lar disease. Other functions of HDL include participation in the shuttling of Apo C and Apo E proteins between HDL is necessary for the uptake of remnants by the liver, as the receptor binding is inhibited by Apo C proteins. nascent triglyceride-rich lipoproteins and their remnants, transport of clusterin and paraoxonase, delivery of choMoreover, donation of Apo C and Apo E to the nascent VLDL and chylomicrons by HDL is critical for their lesterol to steroidogenic glands (for example, adrenal and gonads), adsorption of bacterial endotoxins, inhibisubsequent lipolysis by lipoprotein lipase (LPL). This is because Apo E is necessary for their binding to the tion of platelet aggregation (via regulation of Cox-2), and modulation of cytokine-mediated endothelial adhesion endothelial surface and Apo C-II is necessary for activation of LPL. Finally, the lipid-loaded HDL particle binds molecule expression [29] . The main apoprotein constituents of HDL are Apo A-I (70% of HDL protein) and to the newly discovered HDL receptor, which serves as by urinary losses of proteins of intermediate molecular weight; the molecular mass of LCAT (63 kD) is very close to that of albumin. In contrast to the nephrotic animals, the Nagase rats with hereditary analbuminemia showed normal LCAT mRNA abundance in the liver and normal plasma and urine LCAT activity. These observations suggested that LCAT deficiency in NS is due to proteinuria, not hypoalbuminemia.
In the presence of LCAT deficiency, accumulation of unprocessed free cholesterol on the surface of HDL limits the gradient-driven cholesterol uptake by HDL. This limitation leads to a rise in cellular cholesterol and impaired maturation of cholesterol-poor HDL-3 to choles- Apo C-II and Apo E between nascent VLDL and chylomicrons and their remnants [35] . Among HDL species, HDL-2 is the most efficient donor of Apo C-II and a docking platform for the HDL-2 particle [30] . The Apo E. Therefore, an LCAT deficiency-induced reducreversible binding to the receptor facilitates unloading of tion of HDL-2 reduces Apo C-II (cofactor of lipoprotein the HDL's cholesterol ester content into the hepatocyte.
lipase) and Apo E (ligand for endothelial heparan sulThis transfer of the cholesterol ester is accompanied by fate) in VLDL and chylomicrons, which, in turn, can extraction of the fatty acids derived from hydrolysis of depress lipolysis of VLDL and chylomicrons and protriglyceride content of HDL by hepatic triglyceride limote hypertriglyceridemia. Unlike rats, humans possess pase. The lipid-depleted HDL-3 particle disassociates CETP, which catalyzes the exchange of triglycerides in from the HDL receptor and returns to the circulation, VLDL remnants for cholesterol ester in HDL. Therewhere it serves as a recycling shuttle (Fig. 1) . In addition fore, reduction in the cholesterol ester content of HDL, to the HDL receptor-mediated pathway, which results occasioned by LCAT deficiency in humans, can limit in the exclusive removal of HDL lipid contents, some maturation of VLDL remnants and lead to generation HDL particles containing Apo E can be removed in their of abnormal particles with a high-triglyceride content. entirety by hepatic LRP or LDL receptor. Plasma HDL Thus, the severe LCAT deficiency shown in our study concentration is frequently reduced [6] or unchanged [32] can contribute to the reported abnormalities of HDL [1] and LDL/HDL ratio is markedly elevated in NS. In maturation and metabolism [31] , as well as to impaired addition, maturation of lipid-poor HDL-3 to cardioproclearance and abnormal composition of VLDL and chytective cholesterol-rich HDL-2 is impaired and leads to lomicrons and their remnants in NS [1, [7] [8] [9] 36] , coma significant elevation of HDL-3 and a marked reduction pounding the effects of lipoprotein lipase, hepatic triglycin HDL-2 in NS [31] .
eride lipase, and VLDL receptor deficiencies [37] [38] [39] . Given the critical role of LCAT in maturation of choApo A-I (molecular mass, 28 kD) is the main structural lesterol-poor HDL-3 to cholesterol ester-rich cardioprocomponent of HDL, the obligate cofactor for LCAT, tective HDL-2, we hypothesized that the elevation of and the likely ligand for the HDL binding protein (vig-HDL-3/HDL-2 ratio, as well as the relative reduction of ilin) and HDL receptor (SR-B1). Synthesized by the HDL cholesterol to total cholesterol in NS, might be liver and intestine, it is primarily catabolized by liver, indicative of LCAT deficiency. To test this hypothesis, kidney, skin, and other tissues. Hepatic Apo A-I mRNA we recently studied expression of LCAT mRNA in the is increased, its fractional catabolic rate is reduced, and liver and enzymatic activity and protein concentration despite its urinary losses, plasma Apo A-I concentration of LCAT in the plasma and urine of nephrotic rats. We is elevated in nephrotic rats [40, 41] . In contrast to rats, compared the results with those obtained in Nagase rats fractional catabolism of Apo A-I is often elevated in with hereditary analbuminemia and normal control aninephrotic humans [42] . The observed disparity appears mals [16, 32] . The study revealed a marked reduction of to be due to the absence in the rat [43] and upregulation plasma LCAT and heavy urinary losses of the enzyme in in nephrotic humans [44] of CETP, which catalyzes transthe nephrotic group. Plasma LCAT activity was inversely fer of cholesterol esters from HDL-2 to VLDL remnants. related to its urinary excretion. However, LCAT mRNA This process favors formation of HDL-3; HDL-3's affinabundance in the liver tissue was not altered by NS.
ity for Apo A-I is less than that of HDL-2 [45] . Therefore, These findings suggested that the urinary losses contriban increased level of cholesterol-ester-poor HDL-3 occasioned by elevated CETP [44] , and reduced LCAT [32] ute to LCAT deficiency in NS, a condition characterized can contribute to elevation of unincorporated Apo A-I, ated uptake of surplus cholesterol from extrahepatic tissues. This limitation can contribute to the reported which, owing to its small size, is susceptible to urinary excretion and catabolism in the kidney [41] .
abnormalities of HDL, VLDL, chylomicrons, and their remnants in NS. Impaired HDL-mediated cholesterol As I said earlier, HDL plays an important role in the reverse transport of cholesterol from the extrahepatic uptake from the extrahepatic tissues is compounded by marked reduction of the hepatic HDL receptor, which tissues to the liver, as well as delivery of cholesterol esters to nonplacental steroidogenic tissues (gonads and adrecan limit HDL-mediated cholesterol (and triglyceride) disposal in the liver. These events work in concert to nal glands). Prior to discovery of the HDL receptor, the mechanism of cholesterol uptake from HDL by liver limit reverse cholesterol transport and hence cardiovascular, and perhaps renoprotective, actions of HDL. Inand the steroidogenic glands was unknown. The HDL receptor, originally identified by Acton and colleagues as deed, they probably contribute to cardiovascular complications in chronic nephrosis. an SR-B1 molcule, is a cell membrane-associated protein, which is expressed in the liver, adrenal glands, testes, Triglyceride-rich lipoprotein metabolism and ovaries and which has a high affinity for HDL. Cells transfected with the HDL receptor gene exhibit a strong
The critical role of lipids in energy metabolism is evidenced by the fact that as much as 80% of energy prosaturable binding affinity for HDL. Binding of HDL to its receptors on the transfected cells removes its lipid duced in the body passes through some lipid intermediary. Triglyceride-rich lipoproteins, which consist of chylocontents without uptake or degradation of the HDL apoprotein constituents [30] . Reversible binding of HDL to microns, VLDL, and their remnants, are the primary vehicles for transport of fatty acids (as triglycerides) the HDL receptor on the surface of the hepatocyte unloads cholesterol esters from the core of HDL into the among the sites of absorption, production, storage, and consumption. In addition, albumin binds and transports hepatocyte. In addition, binding to the receptor facilitates lipolysis of triglycerides in the HDL by hepatic triglycerfree fatty acids and lysolecithins. Chylomicrons serve as the vehicle for transport of ide lipase and removal of fatty acids by the liver. Thus, unlike the LDL receptor, the HDL receptor serves as a dietary lipids. Nascent chylomicrons are produced in the enterocytes from fatty droplets containing triglycerides, docking receptor that allows HDL to operate as a recycling shuttle for cholesterol transport from the extrahephospholipids, and cholesterol esters supplemented with an array of apoproteins including Apo B-48, Apo A-I, patic tissues to the liver and steroidogenic glands. Notably, hepatic removal and catabolism of Apo A-I involve Apo A-II, and Apo A-IV. After being released in the circulation via the lymphatic system, nascent chyloa different and as-yet-unidentified pathway with niacinresponsive and niacin-unresponsive components [46] . microns acquire free cholesterol, Apo C, and Apo E from HDL in exchange for Apo A-I, Apo A-II, and To discern the possible effect of NS on hepatic HDL receptor expression, we studied HDL receptor mRNA phospholipid. Acquisition of Apo C and Apo E from HDL is essential for the subsequent lipolysis of chylomiand immunodetectable HDL receptor protein abundance in rats with chronic NS [47] . The nephrotic animals crons by lipoprotein lipase, which requires Apo C-II for enzymatic activity and Apo E for particle binding to the showed marked down-regulation of hepatic HDL receptor protein expression that was accompanied by a normal endothelial surface (Fig. 2) . Very-low-density lipoprotein is the vehicle for trans-HDL receptor mRNA abundance. Thus, NS appears to affect the hepatic HDL receptor at the level of protein port of endogenous lipids. Nascent VLDL is produced in the hepatocyte from fusion of partially lipidated, newly in a manner virtually identical to that seen with LDL receptor expression [20] . Combined down-regulation of synthesized Apo B-100 with a triglyceride-rich particle and subsequent addition of Apo E, Apo A-I, and Apo the hepatic HDL receptor and LDL receptor, which represent the two major pathways of plasma cholesterol A-II. After release into the circulation, nascent VLDL acquires Apo C and Apo E from HDL in exchange for clearance, can play a central role in the pathogenesis of nephrotic hypercholesterolemia and the associated dysApo A-I, Apo A-II, and additional phospholipid. Again, acquisition of additional Apo E is needed for proper regulation of HMG-CoA reductase and Ch 7␣-hydroxylase expressions [15, 18] . As I noted earlier, in addition to binding, while acquisition of Apo C-II is necessary for optimal lipolysis of VLDL by lipoprotein lipase. Fatty accommodating the removal of cholesterol esters, HDL binding to HDL receptor facilitates hydrolysis of HDL acids used for incorporation into VLDL in the liver are derived from de novo synthesis from surplus carbohytriglycerides by hepatic triglyceride lipase, which is also severely depressed in NS [38] . Thus, combined HDL drates, plasma albumin-bound fatty acid pool and hepatic lipase-mediated lipolysis or receptor-mediated upreceptor and hepatic triglyceride lipase deficiencies can severely affect HDL-dependent lipid transport in NS.
take of IDL, and chylomicron remnants and HDL. Triglyceride-rich lipoproteins deliver fatty acids as In short, proteinuria produces urinary losses of LCAT and severe LCAT deficiency, which limit the HDL-meditriglycerides to various tissues for energy production (skeletal muscle and myocardium) or energy storage (adof lipids and lipoproteins can contribute to the nephrotic hyperlipidemia [48] , impaired clearance of chylomicrons ipose tissue). Delivery of fatty acids to these tissues involves hydrolysis of triglyceride by lipoprotein lipase [49, 50] and VLDL [9, 49] has emerged as the dominant factor. Impaired VLDL and chylomicron clearance in leading to release of two fatty acids, followed by removal of the third fatty acid, which involves a separate monog-NS was originally attributed to proteinuria, not hypoalbuminemia [49] . Recently, however, Shearer et al [50] lyceridase system. Two thirds of the fatty acids released from VLDL and chylomicrons diffuse into the adjacent have demonstrated that both proteinuria and hypoalbuminemia can separately contribute to impaired lipomyocytes or adipocytes for energy production or storage, respectively. However, the remaining free fatty acids enprotein catabolism. Lipoprotein lipase (LPL) is the rate-limiting step in ter the plasma pool bound to albumin or lipoproteins for transport to distant sites, mainly the liver. Lipoprotein lipolysis of VLDL and chylomicrons [51] . This glycoprotein enzyme is a member of the lipase family, which also lipase-mediated lipolysis causes an approximately 70% reduction in triglyceride contents of chylomicrons and includes hepatic triglyceride lipase and pancreatic lipase. Heavily expressed in adipose tissue, skeletal muscle, VLDL under normal conditions. This reduction significantly decreases the particle diameter coupled with parmyocardium, and several other tissues, LPL is produced as an inactive enzyme that requires sequential glycation, tial transfer of phospholipid/free cholesterol monolayer, substantial transfer of Apo E, and total transfer of Apo C glucose trimming, and cleavage of a 27 amino acid peptide to become active. The LPL is then stored in the and Apo A from the shrinking chylomicrons or VLDL to the adjacent HDL. The chylomicron remnants formed Golgi vesicles and directed for either intracellular degradation or secretion to the cell surface [52] . The secreted in this manner are endocytosed by hepatocytes via LRP. In the hepatocyte, part of the triglycerides released from LPL binds to heparan sulfate proteoglycans on the cell surface and eventually translocates to the lumen of the chylomicron remnants is returned to the circulation via newly synthesized VLDL. In the circulation, the VLDL adjacent capillaries, where it attaches to the heparan sulfate on the endothelial cells. Only the endothelialremnants (IDL) donate part of their remaining triglycerides to the nearby HDL in exchange for cholesterol esbound pool of LPL is relevant to lipolysis of VLDL and chylomicrons. Since soluble heparin can displace and ters with the aid of CETP. Thereafter, most of the IDL undergoes further lipolysis by hepatic triglyceride lipase release LPL from the binding sites, measurement of plasma post heparin lipolytic activity or heparin releasand becomes LDL, which normally consists exclusively of Apo B-100 with a core of cholesterol ester and negligiable LPL can be used to investigate LPL activity in humans and animals. Several in vivo studies had demonble amounts of triglycerides (major pathway). The remaining IDLs are removed by the liver via either LDL strated marked reduction of heparin-releasable LPL in nephrotic animals and humans [8, 9, 11, 36, 49, 53, 54]. receptor or LRP (minor pathway) (Fig. 3) .
Plasma concentrations of triglycerides, VLDL, and However, the effect of NS on gene expression and protein abundance of LPL in the relevant tissues such as IDL remnants are markedly elevated, triglyceride content of Apo B-containing lipoproteins is increased, and skeletal muscle, myocardium, and adipose tissue was not known. Our studies showed significant reductions of hepclearance of VLDL and chylomicrons is significantly impaired in NS [1, 7, 9-11]. Although increased production arin-releasable, nonreleasable (intracellular), and total LPL activities in the myocardium and adipose tissues critical role in maturation of IDL to LDL and in triglyceride unloading of HDL-2 in the liver. Plasma IDL is and of total LPL activity in the skeletal muscle of nephrotic rats [37] . These reductions were accompanied by markedly elevated, and composition of HDL is abnormal in NS [1, 5, 6, 8, 9, 11, 58, 59]; both of these alterations marked reductions of LPL protein abundance in all tested tissues and of LPL mRNA in the myocardium. However, point to depressed hepatic lipase activity. In fact, in vitro perfusion of livers from rats with puromycin-induced NS despite significant reductions in LPL activity and protein abundance, LPL mRNA abundance in skeletal muscle yields 50% lower heparin-releasable lipase activity as compared with control rats [9] . We demonstrated that and adipose tissue of the nephrotic rats was unchanged, reflecting post-translational regulation. In earlier studies, the reduction in hepatic lipase activity in NS is due to severe down-regulation of hepatic lipase gene expression we had shown that by increasing the left ventricular workload, hypertension leads to marked up-regulation of LPL [38] . In addition to its role in metabolism of IDL, hepatic lipase plays a major role in the lipolysis of triglycerides expression in the myocardium [55] . Because NS is frequently accompanied by hypertension, coexistent hyperin HDL-2, which depends on its binding to hepatic HDL receptor. Therefore, the combination of HDL receptor tension can modify the effect of NS on cardiac LPL expression. The down-regulation of LPL protein abundance and deficiency [47] and hepatic lipase deficiency [38] can severely affect HDL metabolism in NS. enzymatic activity found in puromycin-induced NS was recently confirmed by our group in nephrotic rats with
The VLDL receptor is a newly recognized member of the LDL receptor family, which binds and internalizes spontaneous focal glomerulosclerosis [56] .
Our studies thus demonstrated marked down-regula-VLDL but not LDL. Tissue distribution of VLDL receptor (skeletal muscle, myocardium, and adipose tissue) is tion of LPL in skeletal muscle, myocardium, and adipose tissue, the principal sites of consumption and storage of similar to that of LPL [60] [61] [62] . In addition to their shared tissue distribution, VLDL receptor and LPL appear to fatty acids. The obvious implication of LPL deficiency relates to its role in the pathogenesis of hyperlipidemia be functionally interdependent [63] . For instance, LPL facilitates binding of VLDL particles to VLDL receptor and the associated risk of cardiovascular disease. The less obvious consequence of severe LPL deficiency is its by forming a bridge between heparan sulfate proteoglycan and VLDL. Nephrotic syndrome is associated with impact on energy metabolism in skeletal and cardiac muscles, which draw much of their energy requirements impaired clearance and elevated plasma concentration of VLDL, which might reflect possible VLDL receptor from fatty acids derived from circulating VLDL via LPL and possibly VLDL receptor. This phenomenon can podeficiency. Therefore, we studied VLDL receptor mRNA and protein abundance in skeletal muscle and myocartentially contribute to diminished exercise capacity and easy fatigability, frequently seen in nephrotic patients.
dium of nephrotic and control rats and found a marked reduction of VLDL receptor protein in both tissues in Hepatic lipase is another member of the lipase family that has considerable structural homology with LPL [57] .
the nephrotic animals. This decrease was coupled with a parallel reduction in VLDL receptor mRNA in the However, hepatic lipase is distinct from LPL in its tissue distribution, substrate specificity (IDL and HDL), and cardiac but not skeletal muscle [39] . In a more recent study, we found a severe progressive reduction of VLDL independence from Apo C-II. Hepatic lipase plays a receptor in the skeletal muscle and adipose tissue of to an LDL-like particle via a disulfide bond. Elevation of plasma LP(a) constitutes an independent risk factor nephrotic rats with spontaneous focal glomerulosclerosis and severe hyperlipidemia [56] . Given De Sain-van der Velden et al [71] determined fractional binding of VLDL from Nagase rats with hereditary analbuminemia is increased. They further showed that defeccatabolic and synthesis rates of LP(a) in a group of 5 nephrotic and 5 normal control individuals. The mean tive binding of nephrotic VLDL can be reversed by preincubation of nephrotic VLDL with HDL from either plasma LP(a) concentration in the nephrotic group was approximately threefold greater than that of the control normal or Nagase rats but not with the nephrotic HDL. Likewise, infusion of normal HDL improved chylogroup. This was accompanied by an increased absolute micron clearance in nephrotic rats. These observations rate of synthesis but a normal fractional catabolic rate pointed to an intrinsic defect of triglyceride-rich lipoproof LP(a), and suggested increased synthesis as the cause teins in nephrotic animals, which was linked to an abnorof elevated plasma LP(a) in NS. mality in nephrotic HDL. Analysis of apoprotein-lipid
Owing to its homology with plasminogen, Apo(a) inratios of VLDL and HDL revealed a significant reducterferes with plasminogen-mediated fibrinolysis. Consetion in the Apo B-to-triglyceride ratio in nephrotic quently, a high plasma LP(a) concentration produces a VLDL and a marked reduction in the Apo E-to-Apo prothrombotic diathesis by promoting an imbalance be-A-I ratio in the nephrotic HDL. A similar reduction in tween coagulation and fibrinolytic systems. This consethe Apo E-to-Apo A-I ratio was reported in HDL from quence is of particular interest because NS results in urinary salt-sensitive Dahl rats with NS [54] . Because HDL is a losses and deficiency of antithrombin III [72] ; marked elesource of Apo E and Apo C for the nascent VLDL, and vations of plasma factor VIII, von Willebrand factor, factor these apoproteins are required for activation and binding XIII, fibrinogen, and fibronectin; and increased platelet to LPL, Shearer et al suggested that Apo E depletion reactivity [73, 74] . The constellation of these abnormaliof nephrotic HDL can contribute to impaired lipolysis ties creates a profound hypercoagulable state marked by of triglyceride-rich lipoproteins by LPL [50] . Similarly, a high incidence of thromboembolic events [74, 75] . a relative reduction of Apo E, which is a ligand for the VLDL receptor, can interfere with its efficient binding CONCLUSION and clearance by VLDL receptor [50] . Lipoprotein lipase
The induction of hypercholesterolemia during the deficiency appears to be partly responsible for diminearly phase of NS is accompanied by, and primarily reished Apo E content of HDL because LPL-mediated lated to, up-regulation of HMG-CoA reductase. Maintelipolysis of VLDL is required for the transfer of Apo C nance of hypercholesterolemia in the chronic phase of NS and Apo E from VLDL remnants to HDL. It is therefore is supported by the up-regulation of hepatic ACAT and intuitive that insufficient lipolysis of VLDL due to LPL down-regulations of LDL receptor and HDL receptor. deficiency can limit the ability of HDL to maintain adeUrinary losses of LCAT result in severe LCAT deficiency, quate supplies of Apo E. This viewpoint is supported by which impairs HDL-mediated cholesterol uptake from the studies by Garber et al [9] , who showed a marked inextrahepatic tissues in NS. This impairment is accompanied crease in Apo E content of HDL following incubation by down-regulation of hepatic HDL receptor (SR-B1), of nephrotic serum with purified LPL in vitro.
which limits HDL-mediated cholesterol and triglyceride Lipoprotein(a) disposal in the liver. These events lead to profound dysregulation of HDL metabolism and undoubtedly limit the Lipoprotein(a) [LP(a)] is formed from the covalent binding of a protein known as apolipoprotein (a) for production of energy in the skeletal muscle and myoupregulation of HMG-CoA reductase in NS. In addition, cardium and the primary form for long-term storage of urinary losses of thyroid hormone and gonadal hormones energy in adipose tissue. Chylomicrons and VLDL are along with their binding proteins can contribute to dysthe primary vehicles for transport of fatty acids (as triregulation of hepatic HMG-CoA reductase expression glycerides) from intestine and liver, respectively. Lipoprotein lipase catalyzes hydrolysis of triglycerides conand activity in NS [76] . Finally, hypoalbuminemia per se tained in VLDL and chylomicrons, and that process leads contributes to up-regulation of HMG-CoA reductase in to release and uptake of free fatty acids by myocytes NS. This supposition is based on our recent study demonand adipocytes. In addition, VLDL receptor appears to strating a marked up-regulation of hepatic HMG-CoA mediate uptake of VLDL, including its triglyceride cargo, reductase protein abundance in rats with hereditary analby myocytes and adipocytes. As I indicated during my buminemia, in which proteinuria is absent (unpublished presentation, NS severely down-regulates the LPL and data). The mechanism by which hypoalbuminemia alters VLDL receptors, and this down-regulation can negaexpression of HMG-CoA reductase and other proteins tively affect energy metabolism by limiting availability of is uncertain. However, it is commonly thought to be fatty acids for energy production and storage in skeletal mediated by an undefined signal evoked by depressed muscle and adipose tissue. plasma oncotic pressure in the hepatic sinusoids, in which Dr. Harrington: Second, you mentioned that there plasma is in direct contact with the hepatocyte. Alternawas a new inhibitor of ACAT that might have some tively, the effect of hypoalbuminemia might be due to potential benefit. Can you tell us more about that? diminished delivery (or increased free forms) of one or Dr. Vaziri: A number of ACAT inhibitors are curmore compounds, such as free fatty acids, hormones, rently under investigation as potential lipid-lowering and minerals, and other materials normally bound to and anti-atherogenic agents. We are currently investigating the effect of an ACAT inhibitor on lipid metabolism in carried by albumin.
animal models of NS and chronic renal failure, both proteinuria. In addition, concomitant chronic renal insufficiency, which down-regulates hepatic LCAT expresof which are associated with marked up-regulation of hepatic ACAT-2 expression. We anxiously await the sion, and NS, which results in urinary losses of LCAT, can lead to severe LCAT deficiency and hence to imcompletion of these studies.
Dr that is frequently accompanied by inflammation and which leads to increased production of positive-phase reactants trants, and other agents. I should note that because of the associated hypoalbuminemia, the biologically active and a relative reduction of negative-phase reactants. To my knowledge, however, this classification has been prifree fraction of HMG-CoA reductase inhibitors can be greater. As such, risk of rhabdomyolysis and hepatic marily applied to plasma proteins, not to the cell-associated proteins, such as HMG-CoA reductase, which is toxicity can be higher in nephrotic patients as compared to the general population. Accordingly, liver function an intracellular enzyme. In fact, as I indicated in my presentation, up-regulation of HMG-CoA reductase in tests and muscle enzyme levels should be closely monitored, and caution should be exercised in determining NS appears to be a response to diminished intracellular free cholesterol, which is occasioned by marked up-reguappropriate drug dosages in nephrotic patients.
Dr. Madias: Is the nephrotic syndrome associated lation of ACAT-2 and down-regulation of LDL receptor and HDL receptor. Accordingly, increased abundance of with any changes in cholesterol-ester transfer protein?
Dr. Vaziri: Yes. Plasma cholesterol-ester transfer prothis enzyme in NS reflects a predictable regulatory response as opposed to a nonspecific characteristic of acutetein (CETP) is markedly elevated in patients with NS. Elevation of CETP, which mediates transfer of cholesphase reactants. On the other hand, LCAT, a liver-derived plasma protein, can potentially behave as a negativeterol ester from HDL to IDL in exchange for triglycerides, is partly responsible for depressed plasma HDL phase reactant. As I noted earlier, LCAT deficiency in NS is largely a consequence of its loss in the urine. cholesterol and elevated HDL triglycerides in NS. Because CETP is absent in rats, we could not study it in Dr. Jaber: What is the effect of HMG-CoA reductase inhibitors on ACAT activity? our rat models. Absence of CETP in rodents is largely responsible for a higher plasma HDL cholesterol concenDr. Vaziri: I do not have a precise answer to this important question at this time, but we are currently tration in these animals and for their natural resistance against atherogenesis.
conducting a series of studies that will provide a definitive answer in the near future. I speculate that the reducDr. Madias: How much do the lipoprotein profile and the activities of the relevant enzymes change in response tion in cholesterol synthesis caused by HMG-CoA reductase inhibition down-regulates ACAT by diminishing the to the superimposition of renal insufficiency on the nephrotic state? need for esterification. the theoretical basis for their potential utility in the man- 39:187-192, 1990 agement of progressive renal disease, regardless of
